Returpen is the results of a collaboration throughout the healthcare ecosystem; Novo Nordisk (pharmaceutical firm) teamed up with governmental our bodies, healthcare suppliers, and diabetes and pharmaceutical associations to create constructive impression on the setting.
The Returpen undertaking is an instance of an integrative partnership. Right here, companions align their missions, methods, values, and actions to attain the precedence aim of making social impression.
On this collaboration, the companions have gone past sharing generic sources and developed a memorandum of understanding the place they comply with be a part of forces to allow the circularity of diabetes pens.
